Franklin Templeton logo

Institution

Franklin Templeton Research & Analysis

Franklin Templeton’s research highlights a strategic focus on navigating the 'Age of Intelligence' and capitalizing on sentiment-driven dislocations in the private credit markets. The firm posits that the software sector is undergoing a structural transformation, with enterprise value shifting away from traditional seat-based models toward AI infrastructure and orchestration platforms. Success in this environment requires a disciplined focus on consumption-based monetization and maintaining gross margin stability as AI-related costs are integrated. Simultaneously, Franklin Templeton observes that while direct lending redemptions have exceeded 2022 levels due to inflation and AI disruption concerns, these pressures are largely driven by investor perception rather than fundamental credit deterioration. This retrenchment has created a tactical opportunity to deploy capital into high-quality credits amid widening spreads and compressed BDC valuations. Ultimately, the firm advocates for a contrarian approach that favors dominant AI operating platforms and high-conviction lending with enhanced downside protection.

8 reports available

Emerging Markets Insights thumbnail

Emerging Markets Insights

Franklin Templeton·Jun 4, 2026

Emerging markets saw gains in May 2026 fueled by AI momentum and potential geopolitical easing. The report highlights that capital discipline is becoming a key differentiator for companies amid ongoing geopolitical and cost pressures.

SpaceX Heads for the IPO Launch Pad thumbnail

SpaceX Heads for the IPO Launch Pad

Franklin Templeton·Jun 6, 2026

This report examines the evolution of SpaceX from a launch provider into a global multi-sector platform company spanning connectivity, defense, and AI. It highlights how early research in private markets allowed the authors to gain conviction before the company's potential IPO.

The IPO Market Reset thumbnail

The IPO Market Reset

Franklin Templeton·Jun 4, 2026

The report argues that the IPO market is undergoing a structural reset as flagship, late-stage private companies transition to public markets. It emphasizes that investors must now track firms earlier in their lifecycle to accurately assess valuation and long-term quality.

Global Equity Pulse thumbnail

Global Equity Pulse

Franklin Templeton·Jun 9, 2026

Franklin Templeton maintains a positive outlook for the global health care sector, citing attractive valuations and internal corporate improvements. The firm advocates for a patient, selective approach focusing on companies with strong product pipelines and defensive growth.

Global Macro Insights thumbnail

Global Macro Insights

Franklin Templeton·Jun 9, 2026

The report highlights that the Middle East conflict is the dominant source of global market uncertainty, influencing inflation, growth, and hawkish central bank policies. Despite this, the firm maintains a positive outlook on select emerging markets and continues to track its 'global rewiring' thesis.

How Innovation is Transforming Biotechnology thumbnail

How Innovation is Transforming Biotechnology

Franklin Templeton·Jun 1, 2026

Biotechnology is entering a multi-year innovation cycle driven by five key trends: scalable gene therapies, multi-purpose drugs, efficient regulatory pathways, AI-driven discovery, and precise drug delivery. These advancements are increasing R&D productivity and expanding addressable markets, making the sector an attractive compounding asset class.

Software in the Age of Intelligence

Franklin Templeton·May 19, 2026

History Does Not Repeat Itself But It Sure Rhymes

Franklin Templeton·May 13, 2026

Sign up to access 2 more reports

All reports

Page 1 of 1

About Franklin Templeton

Visit Website

Get full access

14-day trial · card required